Cargando…

Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver

BACKGROUND: Hepatic de novo lipogenesis (DNL) and β-oxidation are tightly coordinated, and their dysregulation is thought to contribute to the pathogenesis of nonalcoholic fatty liver (NAFL). Fasting normally relaxes DNL-mediated inhibition of hepatic β-oxidation, dramatically increasing ketogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Xiaorong, Fletcher, Justin A., Deja, Stanisław, Inigo-Vollmer, Melissa, Burgess, Shawn C., Browning, Jeffrey D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Clinical Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145942/ https://www.ncbi.nlm.nih.gov/pubmed/36928190 http://dx.doi.org/10.1172/JCI167442

Ejemplares similares

In Vivo Estimation of Ketogenesis Using Metabolic Flux Analysis—Technical Aspects and Model Interpretation
por: Deja, Stanislaw, et al.
Publicado: (2021)

Dietary citrate supplementation enhances longevity, metabolic health, and memory performance through promoting ketogenesis
por: Fan, Shou‐Zen, et al.
Publicado: (2021)

Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2022)

Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and gluconeogenesis in mice
por: Yiew, Nicole K.H., et al.
Publicado: (2023)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and glycerol-mediated gluconeogenesis in mice
por: Yiew, Nicole K.H., et al.
Publicado: (2023)

Association between Impaired Ketogenesis and Metabolic-Associated Fatty Liver Disease
por: Bae, Jaehyun, et al.
Publicado: (2023)

PAQR9 regulates hepatic ketogenesis and fatty acid oxidation during fasting by modulating protein stability of PPARα
por: Lin, Yijun, et al.
Publicado: (2021)

Cinnamic Acid Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Hepatic Lipogenesis and Promoting Fatty Acid Oxidation
por: Wu, You, et al.
Publicado: (2021)

Granulocytic MDSC with Deficient CCR5 Alleviates Lipogenesis and Inflammation in Nonalcoholic Fatty Liver Disease
por: Liao, Tzu-Chieh, et al.
Publicado: (2022)

Swietenine Alleviates Nonalcoholic Fatty Liver Disease in Diabetic Mice via Lipogenesis Inhibition and Antioxidant Mechanisms
por: Mak, Kit-Kay, et al.
Publicado: (2023)

Dietary-Induced Ketogenesis: Adults Are Not Children
por: Porper, Keren, et al.
Publicado: (2021)

SIK2 regulates fasting-induced PPARα activity and ketogenesis through p300
por: Zhang, Zhen-Ning, et al.
Publicado: (2016)

Measurement of lipogenic flux by deuterium resolved mass spectrometry
por: Fu, Xiaorong, et al.
Publicado: (2021)

CREB3L3 controls fatty acid oxidation and ketogenesis in synergy with PPARα
por: Nakagawa, Yoshimi, et al.
Publicado: (2016)

High Fat Diet Upregulates Fatty Acid Oxidation and Ketogenesis via Intervention of PPAR- γ
por: Sikder, Kunal, et al.
Publicado: (2018)

Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
por: Lee, Sejeong, et al.
Publicado: (2023)

Hepatic ketogenesis regulates lipid homeostasis via ACSL1-mediated fatty acid partitioning
por: Ramakrishnan, Sadeesh, et al.
Publicado: (2023)

LOCALIZATION OF THE ENZYMES OF KETOGENESIS IN RAT LIVER MITOCHONDRIA
por: Chapman, M. John, et al.
Publicado: (1973)

Fasting exacerbates hepatic growth differentiation factor 15 to promote fatty acid β-oxidation and ketogenesis via activating XBP1 signaling in liver
por: Zhang, Meiyuan, et al.
Publicado: (2018)

Intermittent fasting induced ketogenesis inhibits mouse epithelial ovarian cancer by promoting antitumor T cell response
por: Udumula, Mary Priyanka, et al.
Publicado: (2023)

Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers
por: Rosqvist, Fredrik, et al.
Publicado: (2019)

Coordination of GPR40 and Ketogenesis Signaling by Medium Chain Fatty Acids Regulates Beta Cell Function
por: Pujol, Julien Benjamin, et al.
Publicado: (2018)

Amphetamine-Like Analogues in Diabetes: Speeding towards Ketogenesis
por: Branis, Natalia M., et al.
Publicado: (2015)

Intermittent Fasting induced ketogenesis inhibits mouse epithelial ovarian tumors by promoting anti-tumor T cell response
por: Udumula, Mary Priyanka, et al.
Publicado: (2023)

Ruscogenin Ameliorates Experimental Nonalcoholic Steatohepatitis via Suppressing Lipogenesis and Inflammatory Pathway
por: Lu, Hung-Jen, et al.
Publicado: (2014)

Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress
por: Ji, Yun, et al.
Publicado: (2019)

Gut Microbiota and Risk of Persistent Nonalcoholic Fatty Liver Diseases
por: Kim, Han-Na, et al.
Publicado: (2019)

Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis
por: Kalra, Sanjay, et al.
Publicado: (2015)

Mammalian autophagy is essential for hepatic and renal ketogenesis during starvation
por: Takagi, Ayano, et al.
Publicado: (2016)

Hepatic Ketogenesis Induced by Middle Cerebral Artery Occlusion in Mice
por: Koch, Konrad, et al.
Publicado: (2017)

Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19
por: Karagiannis, Fotios, et al.
Publicado: (2022)

mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis
por: Martinez Calejman, C., et al.
Publicado: (2020)

Military training elicits marked increases in plasma metabolomic signatures of energy metabolism, lipolysis, fatty acid oxidation, and ketogenesis
por: Karl, J. Philip, et al.
Publicado: (2017)

Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease
por: Lekka, Evangelia, et al.
Publicado: (2022)

p21-activated kinase 4 suppresses fatty acid β-oxidation and ketogenesis by phosphorylating NCoR1
por: Shi, Min Yan, et al.
Publicado: (2023)

Targeted Determination of Tissue Energy Status by LC-MS/MS
por: Fu, Xiaorong, et al.
Publicado: (2019)

S-Allyl cysteine improves nonalcoholic fatty liver disease in type 2 diabetes Otsuka Long-Evans Tokushima Fatty rats via regulation of hepatic lipogenesis and glucose metabolism
por: Takemura, Shigekazu, et al.
Publicado: (2013)

Diosgenin Ameliorated Type II Diabetes-Associated Nonalcoholic Fatty Liver Disease through Inhibiting De Novo Lipogenesis and Improving Fatty Acid Oxidation and Mitochondrial Function in Rats
por: Zhong, Yujie, et al.
Publicado: (2022)

Impact of ketogenesis and strong ion difference on acid-base in our CICU
por: Clark, T, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l3ilj6uor99tbkp6jrrt18lutn